← Back to headlines
mRNA Vaccine and Immunotherapy Reduce Melanoma Recurrence Risk
A new study shows that prophylactic treatment with an mRNA vaccine combined with immunotherapy significantly reduced the risk of melanoma recurrence and death by 49%, and the occurrence of distant metastasis by 59%.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
